Results 111 to 120 of about 16,167 (200)

Use of Mineralocorticoid Receptor Antagonists in Real-world Patients with Heart Failure and Reduced Ejection Fraction: HIJ-HF II study

, 2018
Atsushi Suzuki, Yuko Matsui, Kimiko Nagara, Tsuyoshi Shiga, Nobuhisa Hagiwara   +4 more
openalex   +2 more sources

The Effect of Mineralocorticoid Receptor Antagonists on Heart Failure with Nonreduced Ejection Fraction: A Systematic Review and Meta-Analysis. [PDF]

CJC Open
De Luca C, Bhatt H, Gupta A, Yahyavi A, Banivaheb B, Rayner D, Anderson K, Zieroth S, Virani SA, Foroutan F, Aleksova N.   +10 more
europepmc   +1 more source

Adrenal venous sampling outcomes with and without mineralocorticoid receptor antagonists in primary aldosteronism. [PDF]

BMC Endocr Disord
Thipbumrung S, Manosroi W.
europepmc   +1 more source

Major Adverse Cardiovascular Events in Primary Aldosteronism After Adrenalectomy or Mineralocorticoid Receptor Antagonist Treatment: A Systematic Review and Meta‐Analysis

Chien‐Wei Huang, Tse‐Ying Huang, Yafei Yang, Li‐Yang Chang, Yu‐Kang Tu, Vin‐Cent Wu, Jui‐Yi Chen   +6 more
openalex   +1 more source

Investigating the efficacy of mineralocorticoid receptor antagonists for cardiovascular outcomes in different diseases. [PDF]

ESC Heart Fail
Wang J, Zheng M, Yang Y, Zhang L, Wulasihan M.   +4 more
europepmc   +1 more source

Primary Aldosteronism and the Role of Mineralocorticoid Receptor Antagonists for the Heart and Kidneys. [PDF]

Annu Rev Med, 2023
Cohen JB, Bancos I, Brown JM, Sarathy H, Turcu AF, Cohen DL.   +5 more
europepmc   +1 more source

#3802 Real-world outcomes of switching from steroidal mineralocorticoid receptor antagonists (sMRA) to finerenone in patients with chronic kidney disease and type 2 diabetes (T2DM): a multicenter study in madrid community [PDF]

Beatriz Fernandez, Adriana Puente García, Alejandro Avello, David Arroyo Rueda, Maria De San Miguel Marques Vidas, Clara García Carro, Alberto Ortíz   +6 more
openalex   +1 more source

Dose optimization and utilization trends of mineralocorticoid receptor antagonists in heart failure patients with reduced ejection fraction in Ethiopia. [PDF]

Am Heart J Plus
Hassen M, Worku BT, Solomon T, Demessie MB, Wendie TF, Muhammed OS, Gobezie MY.   +6 more
europepmc   +1 more source

An individual treatment effect approach to predict response to mineralocorticoid receptor antagonists in patients with heart failure and reduced ejection fraction. [PDF]

Eur J Heart Fail
Kobayashi M, Duarte K, Ferreira JP, Baudry G, Monzo L, McMurray JJV, Van Veldhuisen DJ, Pitt B, Zannad F, Girerd N.   +9 more
europepmc   +1 more source

Current practice and perceptions on the use of mineralocorticoid receptor antagonists in the management of heart failure: A cross-sectional study among Indian physicians

Rajeev Garg, Subhash Sonawala, Suvro Banerjee, Aditya Kapoor, Arindam Pande, Amit Sharma, Dharmesh Solanki, P.K Santhoshkumar, Febin Francis, Nitin Zalte, Amarnath Sugumaran, Senthilnathan Mohanasundaram   +11 more
openalex   +1 more source